P24928 (RPB1_HUMAN) Homo sapiens (Human)

DNA-directed RNA polymerase II subunit RPB1 UniProtKBInterProSTRINGInteractive Modelling

1970 aa; Sequence (Fasta) ; (Isoform 2)

Available Structures

35 Experimental Structures

DescriptionPDB IDOligo-stateRangeLigands
The structure of INTAC-PEC complex
7ycx
 Heteromer
A0A481BYI6; A0A481DF93; A0A493TD97; A0A4X1TRS6; A0A4X1TVZ5; A0A4X1VEK9; A0A4X1VKG7; A0A4X1VTX4; F1RKE4; I3LCB2; O00267; P18615; P30153; P60899; P63272; P67775; Q5TA45; Q6P9B9; Q75QN2; Q8IXH7; Q8N201; Q8WX92; Q96HW7; Q9H0H0; Q9H3P2; Q9NV88; Q9NVH2; Q9UL03; 		11-1864
10×ZN; 2×MN; 1×MG;
Assess
Structure of the human Mediator-bound transcription pre-initiation complex
7lbm
 Heteromer
A0JLT2; O15514; O43513; O60244; O75448; O75586; P13984; P18074; P19387; P19388; P19447; P20226; P29083; P29084; P30876; P32780; P35269; P36954; P50613; P51946; P51948; P52434; P52435; P52655; P52657; P53803; P61218; P62487; P62875; Q00403; Q13503; Q13888; Q13889; Q15528; Q6P2C8; Q6ZYL4; Q71SY5; Q92759; Q96G25; Q96HR3; Q96RN5; Q9BTT4; Q9BUE0; Q9H204; Q9H944; Q9NPJ6; Q9NVC6; Q9NWA0; Q9NX70; Q9P086; Q9ULK4; Q9Y2X0; Q9Y3C7; 		10-1657
2×MG; 16×ZN; 1×SF4;
Assess
TFIID-based holo PIC on SCP promoter
7egb
 Heteromer
A0A481BYI6; A0A4X1TRS6; A0A4X1TVZ5; A0A4X1VEK9; A0A4X1VKG7; A0A4X1VTX4; F1RKE4; I3LCB2; I3LCH3; O00268; P13984; P18074; P19447; P20226; P21675; P29083; P29084; P32780; P35269; P49848; P50613; P51946; P51948; P52655; P52657; P60899; Q00403; Q12962; Q13888; Q13889; Q15542; Q15543; Q15544; Q15545; Q16514; Q16594; Q5VWG9; Q6P1X5; Q6ZYL4; Q7Z7C8; Q92759; 		11-1487
17×ZN; 1×SF4; 1×MG;
Assess
p53-bound TFIID-based holo PIC on HDM2 promoter
7egc
 Heteromer
A0A481BYI6; A0A4X1TRS6; A0A4X1TVZ5; A0A4X1VEK9; A0A4X1VKG7; A0A4X1VTX4; F1RKE4; I3LCB2; I3LCH3; O00268; P13984; P18074; P19447; P20226; P21675; P29083; P29084; P32780; P35269; P49848; P50613; P51946; P51948; P52655; P52657; P60899; Q00403; Q12962; Q13888; Q13889; Q15542; Q15543; Q15544; Q15545; Q16514; Q16594; Q5VWG9; Q6P1X5; Q6ZYL4; Q7Z7C8; Q92759; 		11-1487
16×ZN; 1×SF4; 1×MG;
Assess
Human holo-PIC in the closed state
6o9l
 Heteromer
O15514; P13984; P18074; P19387; P19388; P19447; P20226; P23193; P29083; P29084; P30876; P32780; P35269; P36954; P50613; P51946; P51948; P52434; P52435; P52655; P52657; P53803; P61218; P62487; P62875; Q00403; Q13888; Q13889; Q6ZYL4; Q92759; 		10-1485
2×MG; 17×ZN; 1×SF4;
Assess
Human core-PIC in the open state
5iyb
 Heteromer
O15514; P13984; P19387; P19388; P20226; P23193; P29083; P29084; P30876; P35269; P36954; P52434; P52435; P52655; P52657; P53803; P61218; P62487; P62875; Q00403; 		10-1485
2×MG; 11×ZN;
Assess
Human holo-PIC in the initial transcribing state
5iy8
 Heteromer
O15514; P13984; P18074; P19387; P19388; P19447; P20226; P23193; P29083; P29084; P30876; P35269; P36954; P52434; P52435; P52655; P52657; P53803; P61218; P62487; P62875; Q00403; Q13888; Q13889; Q6ZYL4; Q92759; 		10-1485
2×MG; 11×ZN;
Assess
Human core-PIC in the initial transcribing state
5iyc
 Heteromer
O15514; P13984; P19387; P19388; P20226; P23193; P29083; P29084; P30876; P35269; P36954; P52434; P52435; P52655; P52657; P53803; P61218; P62487; P62875; Q00403; 		10-1485
2×MG; 11×ZN;
Assess
Human core-PIC in the closed state
5iya
 Heteromer
O15514; P13984; P19387; P19388; P20226; P23193; P29083; P29084; P30876; P35269; P36954; P52434; P52435; P52655; P52657; P53803; P61218; P62487; P62875; Q00403; 		10-1485
2×MG; 11×ZN;
Assess
Human holo-PIC in the closed state
5iy6
 Heteromer
O15514; P13984; P18074; P19387; P19388; P19447; P20226; P23193; P29083; P29084; P30876; P35269; P36954; P52434; P52435; P52655; P52657; P53803; P61218; P62487; P62875; Q00403; Q13888; Q13889; Q6ZYL4; Q92759; 		10-1485
2×MG; 11×ZN;
Assess
Human holo-PIC in the open state
5iy7
 Heteromer
O15514; P13984; P18074; P19387; P19388; P19447; P20226; P23193; P29083; P29084; P30876; P35269; P36954; P52434; P52435; P52655; P52657; P53803; P61218; P62487; P62875; Q00403; Q13888; Q13889; Q6ZYL4; Q92759; 		10-1485
2×MG; 11×ZN;
Assess
Human core-PIC in the initial transcribing state (no IIS)
5iyd
 Heteromer
O15514; P13984; P19387; P19388; P20226; P29083; P29084; P30876; P35269; P36954; P52434; P52435; P52655; P52657; P53803; P61218; P62487; P62875; Q00403; 		10-1485
2×MG; 11×ZN;
Assess
Human holo-PIC in the initial transcribing state (no IIS)
5iy9
 Heteromer
O15514; P13984; P18074; P19387; P19388; P19447; P20226; P29083; P29084; P30876; P35269; P36954; P52434; P52435; P52655; P52657; P53803; P61218; P62487; P62875; Q00403; Q13888; Q13889; Q6ZYL4; Q92759; 		10-1485
2×MG; 10×ZN;
Assess
Structure of the p53/RNA polymerase II assembly
6xre
 Heteromer
O15514; P04637; P19387; P19388; P30876; P36954; P52434; P52435; P53803; P61218; P62487; P62875; 		19-1485
1×MG; 8×ZN;
Assess
RNA Pol II(G)
6drd
 Heteromer
O15514; P0CAP2; P19387; P19388; P30876; P36954; P52434; P52435; P53803; P61218; P62487; P62875; 		364-1484
5×ZN;
Assess
Influenza B polymerase with Pol II pSer5 CTD peptide mimic bound in site 2B
7z42
 Heteromer
Q5V8X3; Q5V8Y6; Q5V8Z9; 		1713-1733
Assess
Bat influenza A/H17N10 polymerase bound to four heptad repeats of serine 5 phosphorylated Pol II CTD
5m3h
 Heteromer
H6QM90; H6QM91; H6QM92; 		1713-1727
1×ZN; 15×PO4;
Assess
Crystal structure of SR-related and CTD-associated factor 4(SCAF4-CID)with peptide S2,S5p-CTD
6xkb
 Heteromer
O95104; 		1787-1800
1×UNX;
Assess
Crystal structure of the SPOC domain of human PHF3 in complex with RNA polymerase II CTD diheptapep…
6ic9
 Heteromer
Q92576; 		1790-1802
Assess
TDRD3 complex
2lto
 Heteromer
Q9H7E2; 		1804-1816
Assess
A mechanism for the activation of the influenza virus transcriptase
6f5p
 Heteromer
Q9IMP3; Q9IMP4; Q9IMP5; 		1716-1727
4×MG;
Assess
CID of human RPRD1A in complex with a phosphorylated peptide from RPB1-CTD
4jxt
 Heteromer
Q96P16; 		1788-1798
6×UNX;
Assess
Crystal structure of the SPOC domain of human PHF3 in complex with RNA polymerase II CTD diheptapep…
6ic8
 Heteromer
Q92576; 		1790-1800
Assess
Snapshots of the RNA processing factor SCAF8 bound to different phosphorylated forms of the Carboxy…
3d9l
 Heteromer
Q9UPN6; 		1790-1799
1×ACT;
Assess
Crystal structure of the SPOC domain of human PHF3 in complex with RNA polymerase II CTD diheptapep…
6q5y
 Heteromer
Q92576; 		1792-1801
Assess
Snapshots of the RNA processing factor SCAF8 bound to different phosphorylated forms of the Carboxy…
3d9m
 Heteromer
Q9UPN6; 		1795-1803
1×NH4; 3×SO4;
Assess
Snapshots of the RNA processing factor SCAF8 bound to different phosphorylated forms of the Carboxy…
3d9o
 Heteromer
Q9UPN6; 		1795-1803
1×NH4; 3×SO4;
Assess
Snapshots of the RNA processing factor SCAF8 bound to different phosphorylated forms of the Carboxy…
3d9k
 Heteromer
Q9UPN6; 		1790-1798
4×SO4;
Assess
Influenza B polymerase bound to four heptad repeats of serine 5 phosphorylated Pol II CTD
5m3j
 Heteromer
Q5V8X3; Q5V8Y6; Q5V8Z9; 		1719-1727
Assess
Crystal Structure of the first bromodomain of human BRD4 in complex with an acetylated POLR2A pepti…
6g0r
 Heteromer
O60885; 		773-780
1×EDO;
Assess
Snapshots of the RNA processing factor SCAF8 bound to different phosphorylated forms of the Carboxy…
3d9n
 Heteromer
Q9UPN6; 		1795-1802
6×SO4;
Assess
Snapshots of the RNA processing factor SCAF8 bound to different phosphorylated forms of the Carboxy…
3d9p
 Heteromer
Q9UPN6; 		1795-1802
4×SO4;
Assess
Crystal structure of the SPOC domain of human SHARP (SPEN) in complex with RNA polymerase II CTD he…
7z1k
 Heteromer
Q96T58; 		1789-1794
Assess
CTD-specific phosphatase Scp1 in complex with peptide from C-terminal domain of RNA polymerase II
2ght
 Heteromer
Q9GZU7; 		1798-1802
1×MG;
Assess
CTD-specific phosphatase Scp1 in complex with peptide C-terminal domain of RNA polymerase II
2ghq
 Heteromer
Q9GZU7; 		1798-1802
1×MG;
Assess

2 SWISS-MODEL models

TemplateOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
7lbm.1.Emonomer0.7510-1657
1×MG; 2×ZN;100.00
Assess
3gtm.1.Amonomer0.706-1485
1×ZN;52.80
Assess

3 SWISS-MODEL models built on isoform sequence

TemplateIsoformOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
Isoform 27egb.1.dmonomer0.8011-562
2×ZN;99.29
Assess
Isoform 28hkc.1.Dmonomer0.5316-557
27.76
Assess
Isoform 27xue.1.Gmonomer0.5021-550
34.21
Assess